Research at Queen'sResearchers
TandemLaunch offering Queen’s graduate students and postdoctoral fellows opportunities to experience the entrepreneurial journey
Feb 14, 2022
An exciting new partnership between Queen’s University and TandemLaunch will enable Queen’s graduate students and postdoctoral fellows in STEM gain valuable entrepreneurial training and real-world exposure to the entrepreneurial journey.
Queen’s Partnerships and Innovation grants funding through ŃýĽ§Ö±˛Ą Development Pilot Program
Feb 08, 2022
Three Queen’s researchers have been granted funding through the Queen’s ŃýĽ§Ö±˛Ą Development Pilot Program.
February 1, 2022: U.S. Patent No. 11,236,250 "Switchable water-based paint or coating compositions"
Feb 01, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,236,250
February 1, 2022: U.S. Patent No. 11,237,112 "Reconfigurable surface enhanced raman spectroscopy device and method therefor"
Feb 01, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,237,112
January 25, 2022: U.S. Patent No. 11,229,629 "Inhbitors of mitochondrial fission"
Jan 25, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,229,629
January 18, 2022: U.S. Patent No. 11,226,201 "Automated Mobile Geotechnical Mapping"
Jan 18, 2022
Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,226,201
From research to commercialization to a public offering: a rewarding journey for Queen’s researchers and Forward Water Technologies
Dec 15, 2021
The journey of the switchable water technology developed by a Queen’s University research team is now advancing its forward osmosis clean-water technology toward full commercialization.
Queen’s professors develop therapy platform to help mental health professionals’ patients
Nov 24, 2021
Two Queen’s University professors have developed a tool that is proving to not only fill this gap but that can also improve access to care by allowing people to get mental health assistance on their own time, and in between appointments.
Nurenyx’s progress shows startups how to do it
Nov 12, 2021
Nurenyx aims to take the trial to the patient by “virtualizing most of” the research trial process.
November, 9, 2021: U.S. Patent No. U.S. 11,168,064 "Synthesis of thapsigargin, nortrilobolide, and analogs thereof"
Nov 09, 2021
U.S. Patent No. U.S. 11,168,064 "Synthesis of thapsigargin, nortrilobolide, and analogs thereof"
Farhana Zulkernine’s Queen’s lab partners with MarkiTech to measure vital signs remotely
Oct 21, 2021
The Veyetals program allows for a quick scan of your face which will give the nurses your temperature, blood pressure, oxygen, and a host of other readings, saving time and minimizing the chances that health-care workers and other patients get infected.